{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-117439","form_type":"8-K","ticker":"APVO","cik":"0001671584","company_name":"Aptevo Therapeutics Inc.","filed_at":"2024-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.176347+00:00","generated_at":"2026-05-30T10:04:49.577642+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aptevo shareholders approve reverse stock split (1:5–1:37) and dilutive stock issuance","bullets":["Stock issuance and warrant proposal passed (593,301 For, 412,901 Against, 5,355 Abstain).","Reverse stock split approved at ratio of 1-for-5 to 1-for-37; board sets timing and exact ratio.","Adjournment proposal also approved (2,017,270 For, 1,253,171 Against, 9,145 Abstain).","Issuance covers >19.99% of outstanding common stock with price adjustment warrants per Sept 16 agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-117439","json":"https://secwatch.observer/filing/0000950170-24-117439.json","markdown":"https://secwatch.observer/filing/0000950170-24-117439.md","text":"https://secwatch.observer/filing/0000950170-24-117439.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024117439/0000950170-24-117439-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024117439/apvo-20241025.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:04:49.577642+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}